Abstract
Acne vulgaris (AV) and rosacea are among the most common skin disorders treated by dermatologists. While both conditions can affect individuals of all racial and ethnic backgrounds, variations in clinical presentation and approaches to treatment exist. This chapter will review the epidemiology, clinical features, and management of AV and rosacea in darkly pigmented patient populations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115(2): 183–92.
Halder RM, Holmes YC, Bridgeman-Shah S, Kligman A. A clinical pathological study of acne vulgaris in black females. J Invest Dermatol. 1996;106:888.
Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387–94.
Halder RM, Grimes PE, McLaurin CI, Kress MA, Kenney Jr JA. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32(4):388–90.
Child FJ, Fuller LC, Higgins EM, Du Vivier AW. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol. 1999;141(3):512–7.
Goh CL, Akarapanth R. Epidemiology of skin disease among children in a referral skin clinic in Singapore. Pediatr Dermatol. 1994;11(2):125–8.
El-Essawi D, Musial JL, Hammad A, Lim HW. A survey of skin disease and skin-related issues in Arab Americans. J Am Acad Dermatol. 2007;56(6):933–8.
Sanchez MR. Cutaneous diseases in Latinos. Dermatol Clin. 2003;21(4):689–97.
Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184–95.
Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis. 2006;77(1):45–50.
Halder RM. The role of retinoids in the management of cutaneous conditions in blacks. J Am Acad Dermatol. 1998;39(2 Pt 3):S98–103.
Jacyk WK. Adapalene in the treatment of African patients. J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:37–42.
Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328(20):1438–43.
Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048–65.
Kawashima M, Harada S, Loesche C, Miyachi Y. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study. J Dermatol Sci. 2008;49(3):241–8.
Fernandez-Obregon A, Davis MW. The BEST study: evaluating efficacy by selected demographic subsets. Cutis. 2003;71(2 Suppl):18–26.
Shavin J, Weiss J. Implications of the BEST study. Cutis. 2003;71(2 Suppl):35–6.
Taylor SC. Utilizing combination therapy for ethnic skin. Cutis. 2007;80(1 Suppl):15–20.
Callender VD, Preston N, Osborn C, Johnson L, Gottschalk RW. A meta-analysis to investigate the relation between Fitzpatrick skin types and tolerability of Adapalene-benzoyl peroxide topical gel in subjects with mild or moderate acne. J Clin Aesthet Dermatol. 2010;3(8):15–9.
Gollnick HP, Graupe K, Zaumseil RP. Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges. 2004;2(10):841–7.
Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol. 2000;43(2 Pt 3):S47–50.
Draelos ZD, Carter E, Maloney JM, Elewski B, Poulin Y, Lynde C, et al. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439 e1–10.
Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg. 1999;25(1):18–22.
Joshi SS, Boone SL, Alam M, Yoo S, White L, Rademaker A, et al. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. Dermatol Surg. 2009;35(4):638–44. discussion 44.
Yeung CK, Shek SY, Bjerring P, Yu CS, Kono T, Chan HH. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin. Lasers Surg Med. 2007;39(1):1–6.
Rojanamatin J, Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study. Dermatol Surg. 2006;32(8):991–6. discussion 6-7.
Jih MH, Friedman PM, Goldberg LH, Robles M, Glaich AS, Kimyai-Asadi A. The 1450-nm diode laser for facial inflammatory acne vulgaris: dose–response and 12-month follow-up study. J Am Acad Dermatol. 2006;55(1):80–7.
Paithankar DY, Ross EV, Saleh BA, Blair MA, Graham BS. Acne treatment with a 1,450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med. 2002;31(2):106–14.
Wang SQ, Counters JT, Flor ME, Zelickson BD. Treatment of inflammatory facial acne with the 1,450 nm diode laser alone versus microdermabrasion plus the 1,450 nm laser: a randomized, split-face trial. Dermatol Surg. 2006;32(2):249–55. discussion 55.
Tzung TY, Wu KH, Huang ML. Blue light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed. 2004;20(5):266–9.
Pollock B, Turner D, Stringer MR, Bojar RA, Goulden V, Stables GI, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151(3):616–22.
Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J Am Acad Dermatol. 2006;54(4):647–51.
Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419–23.
Alexis AF. Rosacea in patients with skin of color: uncommon but not rare. Cutis. 2010;86(2): 60–2.
Webster G. Rosacea and related disorders. In: Bolognia J, Jorizzo J, Rapini R, editors. Dermatology. 2nd ed. Philadelphia: Mosby Elsevier; 2008. p. 509–16.
Adler M. Rosacea in patients with darker skin types. Rosacea Acne Brief. 2002;1(4):1–7.
Halder R, Brooks H, Callender V. Acne in ethnic skin. Dermatol Clin. 2003;21(4):609–15.
Kenney Jr JA. Management of dermatoses peculiar to Negroes. Arch Dermatol. 1965;91:126–9.
Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin. 2003;21(4):601–7.
Doe PT, Asiedu A, Acheampong JW, Rowland Payne CM. Skin diseases in Ghana and the UK. Int J Dermatol. 2001;40(5):323–6.
Verhagen AR, Koten JW, Chaddah VK, Patel RI. Skin diseases in Kenya. A clinical and histopathological study of 3,168 patients. Arch Dermatol. 1968;98(6):577–86.
Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46(4):584–7.
Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–41. quiz 42–4.
Koffi-Aka V, Kouassi AA, D’Horpock FA, Boka NJ, Ehouo F. Rhinophyma in a black African. Rev Laryngol Otol Rhinol (Bord). 2002;123(2):109–10.
Khoo CT, Saad MN. Rhinophyma in a Negro: case report. Br J Plast Surg. 1980;33(2):161–3.
Culp B, Scheinfeld N. Rosacea: a review. Phys Ther. 2009;34(1):38–45.
Rosen T, Stone MS. Acne rosacea in blacks. J Am Acad Dermatol. 1987;17(1):70–3.
Williams HC, Ashworth J, Pembroke AC, Breathnach SM. FACE–facial Afro-Caribbean childhood eruption. Clin Exp Dermatol. 1990;15(3):163–6.
Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4): 499–512. quiz 3–4.
Korting HC, Schollmann C. Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol. 2009;23(8):876–82.
van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S. Systematic review of rosacea treatments. J Am Acad Dermatol. 2007;56(1):107–15.
Yoo J, Reid DC, Kimball AB. Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter? J Drugs Dermatol. 2006;5(4):317–9.
Thiboutot D, Thieroff-Ekerdt R, Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol. 2003;48(6):836–45.
Elewski BE, Fleischer Jr AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol. 2003;139(11):1444–50.
Ertl GA, Levine N, Kligman AM. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea. Arch Dermatol. 1994;130(3):319–24.
Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol. 2001;44(6):995–8.
Leyden JJ, Thiboutot D, Shalita A. Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea. Cutis. 2004;73(6 Suppl):11–7.
Ozturkcan S, Ermertcan AT, Sahin MT, Afsar FS. Efficiency of benzoyl peroxide-erythromycin gel in comparison with metronidazole gel in the treatment of acne rosacea. J Dermatol. 2004;31(8):610–7.
Colon LE, Johnson LA, Gottschalk RW. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. Cutis. 2007;79(4):317–21.
Erdogan FG, Yurtsever P, Aksoy D, Eskioglu F. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol. 1998;134(7):884–5.
Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol. 2007;56(5):791–802.
Baldwin HE. Systemic therapy for rosacea. Skin Therapy Lett. 2007;12(2):1–5. 9.
Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol. 1986;25(10):660–3.
Battle Jr EF, Hobbs LM. Laser therapy on darker ethnic skin. Dermatol Clin. 2003;21(4):713–23.
Bhatt N, Alster TS. Laser surgery in dark skin. Dermatol Surg. 2008;34(2):184–94. discussion 94–5.
Clementoni MT, Gilardino P, Muti GF, Signorini M, Pistorale A, Morselli PG, et al. Intense pulsed light treatment of 1,000 consecutive patients with facial vascular marks. Aesthetic Plast Surg. 2006;30(2):226–32.
Erisir F, Isildak H, Haciyev Y. Management of mild to moderate rhinophyma with a radiofrequency. J Craniofac Surg. 2009;20(2):455–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shah, S.K., Alexis, A.F. (2013). Acne and Rosacea in Skin of Color. In: Alexis, A., Barbosa, V. (eds) Skin of Color. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84929-4_2
Download citation
DOI: https://doi.org/10.1007/978-0-387-84929-4_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84928-7
Online ISBN: 978-0-387-84929-4
eBook Packages: MedicineMedicine (R0)